No Data
No Data
Sharecare Is Maintained at Buy by Canaccord Genuity
Sharecare Is Maintained at Buy by Canaccord Genuity
Express News | Canaccord Genuity Maintains Buy on Sharecare, Maintains $2 Price Target
Sharecare Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/21/2024 138.32% Canaccord Genuity $2 → $2 Maintains Buy 04/15/2024 19.16% Morgan Stanley $1.5 → $1 Main
Buy Rating Affirmed for Sharecare Amidst Potential Turnaround and Strategic Review Process
12 Health Care Stocks Moving In Monday's After-Market Session
GainersLarimar Therapeutics (NASDAQ:LRMR) stock increased by 23.6% to $8.99 during Monday's after-market session. The company's market cap stands at $573.5 million. GT Biopharma (NASDAQ:GTBP) stock ro
Sharecare, Inc. (NASDAQ:SHCR) Q1 2024 Earnings Call Transcript
No Data